文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

急性肝衰竭的肝脏弹性成像:一项先导研究

Liver Elastography in Acute Liver Failure: A Pilot Study.
PubMed 文献 · Crit Care Explor · 2024-02-08
一句话结论急性肝衰竭(ALF)患者入院后第5天肝脏硬度达峰值,自发存活者随后下降;第7天时,肝脏硬度测量值(LSM)随预后不同而存在显著差异。

本研究为观察性先导研究,纳入2021年10月至2023年3月国王学院医院肝脏重症监护病房收治的40例ALF患者,以22例慢加急性肝衰竭(ACLF)患者和9名健康对照(HC)作为对照,用ElastPQ测量右叶、左叶及脾脏的剪切波速度,并记录门静脉血流、肝动脉阻力指数和收缩期峰值流速。入院时,右叶LSM在HC、ALF、ACLF三组间存在统计学差异(HC 5.6±2 kPa、ALF 31.7±17 kPa、ACLF 76.3±71 kPa,ALF vs ACLF p=0.0301)。入院时,LSM在90天内自发存活与死亡或移植的ALF患者之间无差异;但入院最初10天内的变化趋势不同,自发存活者第5天LSM达峰值后于恢复期下降,预后不良者LSM持续升高。作者认为,LSM联合脾脏体积与硬度可能有助于区分急性与慢加急性肝衰竭。

要点

  • ALF患者入院后LSM在第5天达峰值,自发存活者随后下降,预后不良者持续升高。
  • 入院时右叶LSM:HC 5.6±2 kPa、ALF 31.7±17 kPa、ACLF 76.3±71 kPa(ALF vs ACLF p=0.0301)。
  • 脾脏大小与硬度可区分ALF(10.4±2 cm、21.4±16.6 kPa)与ACLF(14±2.3 cm、42.6±26 kPa)。
  • 入院时LSM在90天内自发存活与死亡或移植的ALF患者之间无差异。
  • 作者认为LSM联合脾脏体积与硬度可能有助于区分急性与慢加急性肝衰竭。

适用人群与场景

  • 2021年10月至2023年3月国王学院医院肝脏重症监护病房收治的急性肝衰竭患者40例,对照为慢加急性肝衰竭患者22例与健康对照9名。
  • 急性肝衰竭为需要重症监护入住、常需肝移植的罕见危及生命疾病,患者选择至关重要。

研究设计与关键结果

  • 观察性先导研究:纳入40例ALF、22例ACLF、9名健康对照;用ElastPQ测量右叶、左叶及脾脏平均剪切波速度,并记录门静脉血流、肝动脉阻力指数与收缩期峰值流速,结合生理与组织学数据比较。
  • 入院时右叶LSM:健康对照5.6±2 kPa、ALF 31.7±17 kPa、ACLF 76.3±71 kPa(ALF vs ACLF p=0.0301)。
  • 脾脏大小与硬度:ALF 10.4±2 cm与21.4±16.6 kPa,ACLF 14±2.3 cm与42.6±26 kPa。
  • 入院时LSM在90天内自发存活与死亡或移植的ALF患者之间无差异;入院最初10天趋势不同,自发存活者第5天LSM达峰值后恢复期下降,预后不良者LSM持续升高。
  • 结论:ALF患者入院第5天肝脏硬度达峰值,自发存活者随后下降,入院第7天时随预后不同存在显著差异。

证据类型、等级与局限

  • 证据类型:观察性先导研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,LSM联合脾脏体积与硬度可能有助于区分急性肝衰竭与慢加急性肝衰竭。
  • ALF患者入院最初10天内可连续监测LSM变化趋势,自发存活者第5天达峰值后下降,预后不良者持续升高;原文未据此给出治疗推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: We aimed to assess the feasibility and reliability of sequential ultrasonographic and elastographic monitoring in acute liver failure (ALF).

DESIGN: Observational study.

SETTING: ALF is a rare, life-threatening disease that requires intensive care admission and often liver transplant, where the accurate selection of patients is crucial. Liver elastography is a noninvasive tool that can measure hepatic stiffness, but previous results have been inconclusive in ALF.

PATIENTS: Patients admitted between October 2021 and March 2023 to the Liver Intensive Therapy Unit at King's College Hospital with ALF were recruited, with healthy control (HC) individuals and acute-on-chronic liver failure (ACLF) used as controls.

MEASUREMENTS: Average shear wave velocity was recorded with ElastPQ on the right and left liver lobes and the spleen. Portal vein flow, hepatic artery resistive index, and peak systolic velocity were also recorded. Physiologic and histologic data were used for comparison.

MAIN RESULTS: Forty patients with ALF, 22 patients with ACLF, and 9 HC individuals were included in the study. At admission, liver stiffness measurement (LSM) of the right lobe was statistically different between HC individuals (5.6 ± 2 kPa), ALF (31.7 ± 17 kPa), and ACLF (76.3 ± 71 kPa) patients (ALF vs. ACLF, p = 0.0301). Spleen size and stiffness discriminated between ALF (10.4 ± 2 cm and 21.4 ± 16.6 kPa) and ACLF (14 ± 2.3 cm and 42.6 ± 26 kPa). At admission, LSM was not different between ALF patients who spontaneously survived versus patients who died or were transplanted in the following 90 days. However, the trend over the first 10 days of admission was different with a peak of LSM at day 5 in spontaneous survivors followed by reduction during the recovery phase. ALF patients with poor prognosis showed a persistently increased LSM.

CONCLUSIONS: In ALF stiffness peaks at day 5 of admission with subsequent reduction in patients spontaneously surviving, showing significant difference according to the prognosis at day 7 of admission. LSM might be useful in distinguishing acute from acute-on-chronic liver failure together with spleen volume and stiffness.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Trovato FM, Artru F, Miquel R, et al. Liver Elastography in Acute Liver Failure: A Pilot Study. Crit Care Explor. 2024. PMID: 38343443. doi:10.1097/CCE.0000000000001048

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。